Sign in
CompletedNo phase

The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment

Key facts

Who runs it
Zhongshan Hospital (Xiamen), Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
72 people enrolled
Started
31 Jan 2024
Ended
28 Feb 2025
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vonoprazan
  • Amoxicillin
  • Bacillus subtilis enteric-coated capsules
Record updated
13 May 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Age from 18 to 65 years
  • H.pylori infection diagnosed by 13C-urea breath test
  • A period of more than two months since the last eradication therapy for H. pylori
  • Patients who had previously failed 2 or more eradication regimens

Who cannot take part

  • Coexistence of significant concomitant illnesses, including heart disease, renal failure, hepatic disease, previous abdominal surgery, lactation, or pregnancy
  • Allergy to any of the medications
  • Zollinger-Ellison syndrome, GC, Upper gastrointestinal bleeding, or Active peptic ulcer
  • Patients who had used probiotics, vonoprazan, and antibiotics in the past 12 weeks
  • Unwillingness to participate in this study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study was to evaluate the effects of High-dose Dual therapy combined with probiotics on the gut microbiota for Helicobacter pylori rescue treatment.

The 4 groups in the trial

  • Group ATreatment being tested

    vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days, followed by 2 doses of bacillus subtilis enteric-coated capsules for 14 days.

    Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules

  • Group BTreatment being tested

    vonoprazan 20 mg bid + amoxicillin 0.75 g qid+ 2 doses of bacillus subtilis enteric-coated capsules for 14 days.

    Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules

  • Group CTreatment being tested

    2 doses of bacillus subtilis enteric-coated capsules for 14 days, followed by vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days.

    Treatment: Vonoprazan, Amoxicillin, and Bacillus subtilis enteric-coated capsules

  • Group DExisting treatment, for comparison

    vonoprazan 20 mg bid + amoxicillin 0.75 g qid for 14 days.

    Treatment: Vonoprazan and Amoxicillin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of High-dose Dual Therapy Combined With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment: A Prospective, Multicenter, Randomized Trial
Record updated
13 May 2025